Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.

Animals Bacterial Infections / immunology C-Reactive Protein / chemistry Host-Pathogen Interactions / immunology Humans Phosphorylcholine / metabolism Pneumococcal Infections / immunology Protein Binding Streptococcus pneumoniae / immunology Structure-Activity Relationship
C-reactive protein Streptococcus pneumoniae factor H phosphocholine pneumococcal C-polysaccharide

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 28 11 2018
accepted: 18 01 2019
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 17 1 2020
Statut: epublish

Résumé

One host defense function of C-reactive protein (CRP) is to protect against

Identifiants

DOI: 10.3389/fimmu.2019.00166 PMID: 30863393 PMC: PMC6400226
pubmed: 30863393
doi: 10.3389/fimmu.2019.00166
pmc: PMC6400226
doi:

Substances chimiques

Phosphorylcholine 107-73-3
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

166

Subventions

Organisme : NIAID NIH HHS
ID : R56 AI117730
Pays : United States

Références

PLoS One. 2018 May 31;13(5):e0198375
pubmed: 29851992
J Endotoxin Res. 2004;10(3):163-74
pubmed: 15198851
J Immunol. 2017 Jul 1;199(1):292-303
pubmed: 28533443
J Biol Chem. 2016 Apr 15;291(16):8795-804
pubmed: 26907682
Infect Immun. 2013 Jul;81(7):2606-15
pubmed: 23649097
Mol Microbiol. 1998 Nov;30(4):767-75
pubmed: 10094625
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14584-9
pubmed: 11121061
J Biol Chem. 2004 Dec 10;279(50):52552-7
pubmed: 15456743
J Immunol. 2003 Dec 1;171(11):6046-51
pubmed: 14634117
J Immunol. 1999 Oct 1;163(7):3957-62
pubmed: 10490997
Structure. 1999 Feb 15;7(2):169-77
pubmed: 10368284
FASEB J. 2007 Jan;21(1):284-94
pubmed: 17116742
J Immunol. 2002 Jun 15;168(12):6375-81
pubmed: 12055255
J Immunol. 2006 Jun 15;176(12):7612-20
pubmed: 16751408
Exp Mol Med. 2017 Apr 21;49(4):e320
pubmed: 28428631
Cell Death Differ. 2009 Dec;16(12):1630-40
pubmed: 19680263
J Immunol. 1995 Sep 1;155(5):2557-63
pubmed: 7650385
BMC Microbiol. 2010 Jul 12;10:190
pubmed: 20624274
Infect Chemother. 2013 Dec;45(4):351-66
pubmed: 24475349
J Immunol. 2010 Dec 1;185(11):6899-910
pubmed: 21037097
J Immunol. 2001 Mar 15;166(6):3998-4004
pubmed: 11238646
Infect Immun. 2008 Feb;76(2):588-600
pubmed: 17984210
Biomolecules. 2012 Feb 07;2(1):46-75
pubmed: 24970127
J Exp Med. 1941 Jan 31;73(2):173-82
pubmed: 19871070
J Immunol. 2015 May 15;194(10):4963-73
pubmed: 25855355
Scand J Immunol. 1997 Dec;46(6):597-600
pubmed: 9420623
Sci Rep. 2018 Jan 26;8(1):1643
pubmed: 29374201
J Biol Chem. 2008 Nov 7;283(45):30451-60
pubmed: 18786923
Infect Immun. 2000 Oct;68(10):5652-6
pubmed: 10992466
Biochim Biophys Acta. 2016 Jun;1860(6):1118-28
pubmed: 26922829
Proc Natl Acad Sci U S A. 1970 Sep;67(1):138-42
pubmed: 4394061
FASEB J. 2011 Sep;25(9):3186-96
pubmed: 21670067
Front Immunol. 2021 Jan 20;11:620784
pubmed: 33552084
J Immunol. 1982 May;128(5):2374-6
pubmed: 7061864
J Exp Med. 1998 Feb 16;187(4):631-40
pubmed: 9463413
Ann N Y Acad Sci. 1982;389:39-48
pubmed: 7046585
Front Immunol. 2015 May 06;6:215
pubmed: 25999953
J Biol Chem. 2010 Mar 26;285(13):9898-9907
pubmed: 20118243
Biol Chem. 2015 Nov;396(11):1181-97
pubmed: 26040008
Nat Commun. 2017 Jan 23;8:14188
pubmed: 28112148
J Biol Chem. 2012 Jan 27;287(5):3550-8
pubmed: 22158621
Infect Immun. 1982 Oct;38(1):392-5
pubmed: 6815093
Carbohydr Res. 1972 Apr;22(1):1-4
pubmed: 4114890
J Biol Chem. 2000 Nov 24;275(47):37257-63
pubmed: 10967103
Mol Microbiol. 2000 Jan;35(1):234-45
pubmed: 10632893
Biochem J. 1990 Feb 15;266(1):283-90
pubmed: 2310378
Proc Soc Exp Biol Med. 1971 Feb;136(2):612-4
pubmed: 4395924
J Immunol. 1997 Jan 1;158(1):345-50
pubmed: 8977209
EMBO J. 2007 Jul 25;26(14):3431-40
pubmed: 17581635
Annu Rev Immunol. 2005;23:337-66
pubmed: 15771574
Cardiovasc Drugs Ther. 2011 Oct;25(5):379-91
pubmed: 21805404
J Immunol. 2014 Dec 1;193(11):5699-708
pubmed: 25344472
Mol Microbiol. 2000 Mar;35(6):1550-9
pubmed: 10760154
Mediators Inflamm. 2014;2014:319215
pubmed: 24948846
J Biol Chem. 2006 Aug 25;281(34):24713-20
pubmed: 16787919
Acta Biol Hung. 2014 Sep;65(3):265-73
pubmed: 25194730
J Biol Chem. 2010 Nov 12;285(46):36235-44
pubmed: 20843812
Immunology. 2014 Jul;142(3):414-20
pubmed: 24673624
J Immunol. 1984 Aug;133(2):882-5
pubmed: 6234363
J Immunol. 1982 Jun;128(6):2493-6
pubmed: 7077077
Clin Chem. 2011 Oct;57(10):1398-405
pubmed: 21821723
J Immunol. 2011 Oct 15;187(8):4374-83
pubmed: 21930971
Lancet. 2009 Oct 31;374(9700):1543-56
pubmed: 19880020
J Phys Chem B. 2017 Mar 30;121(12):2631-2639
pubmed: 28225631
J Immunol. 2012 Oct 1;189(7):3575-84
pubmed: 22925928
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2575-80
pubmed: 9122237
J Immunol. 2002 Feb 15;168(4):1886-94
pubmed: 11823523
Sci Rep. 2016 Mar 10;6:22889
pubmed: 26961257
Mol Immunol. 2009 Dec;47(2-3):215-21
pubmed: 19853918
Clin Exp Immunol. 1972 Jun;11(2):283-9
pubmed: 4402700
Int Sch Res Notices. 2014 Dec 15;2014:653045
pubmed: 27433484
Infect Immun. 2008 Mar;76(3):1298-304
pubmed: 18195032
Microbiol Immunol. 2000;44(5):335-40
pubmed: 10888350
J Immunol. 2002 Dec 15;169(12):7019-25
pubmed: 12471137
J Biol Chem. 2017 Feb 24;292(8):3129-3136
pubmed: 28096464
J Immunol. 2007 Jan 15;178(2):1158-1163
pubmed: 17202380
Circulation. 2014 Jul 1;130(1):35-50
pubmed: 24982116
J Immunol. 1994 Jun 1;152(11):5404-10
pubmed: 8189060
J Biol Chem. 2012 Dec 14;287(51):43116-25
pubmed: 23139417
J Immunol. 2007 Mar 15;178(6):3831-6
pubmed: 17339482
J Immunol. 1992 Jul 15;149(2):445-53
pubmed: 1624792
Immunopharmacology. 1999 May;42(1-3):81-90
pubmed: 10408369
Glycoconj J. 2006 Jul;23(5-6):317-27
pubmed: 16897175
PLoS Pathog. 2009 Jan;5(1):e1000282
pubmed: 19180241
J Immunol. 2002 Sep 15;169(6):3217-22
pubmed: 12218140
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):1-14
pubmed: 27864148
J Immunol. 2006 Apr 1;176(7):4369-74
pubmed: 16547275
Colloids Surf B Biointerfaces. 2018 Jan 1;161:662-669
pubmed: 29172154
PLoS One. 2011;6(12):e28738
pubmed: 22174882
Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):231-7
pubmed: 19075776
J Biol Chem. 2010 Jan 8;285(2):1053-65
pubmed: 19850925
J Exp Med. 1930 Sep 30;52(4):561-71
pubmed: 19869788
Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6
pubmed: 1692629
J Biol Chem. 2007 Apr 13;282(15):10894-900
pubmed: 17293598
Nat Struct Biol. 1996 Apr;3(4):346-54
pubmed: 8599761
Mol Microbiol. 2002 Jan;43(2):437-48
pubmed: 11985720
J Biol Chem. 2007 Jun 29;282(26):18960-8
pubmed: 17360715
Clin Exp Immunol. 1998 Sep;113(3):353-9
pubmed: 9737662
Infect Immun. 2015 May;83(5):1845-52
pubmed: 25690104
J Immunol. 1981 Nov;127(5):2089-92
pubmed: 6913608
Sci Rep. 2018 Jan 24;8(1):1494
pubmed: 29367639
PLoS One. 2012;7(9):e44135
pubmed: 22957048
Vascul Pharmacol. 2015 Oct;73:38-44
pubmed: 25962566
Mol Immunol. 2010 Mar;47(6):1347-55
pubmed: 20042240
Front Immunol. 2018 Jun 12;9:1351
pubmed: 29946323
Vaccine. 2008 Dec 30;26 Suppl 8:I67-74
pubmed: 19388168
J Immunol. 2012 Dec 1;189(11):5327-35
pubmed: 23105137
Clin Exp Immunol. 1983 Nov;54(2):319-26
pubmed: 6652963
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3623-7
pubmed: 22308483
N Engl J Med. 1995 May 11;332(19):1280-4
pubmed: 7708073
J Immunol. 1974 Jun;112(6):2135-47
pubmed: 4151108

Auteurs

Donald N Ngwa (DN)

Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.

Alok Agrawal (A)

Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Immunoprotéines › Protéine C-réactive › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Phénomènes biologiques › Interactions hôte-microbes › Interactions hôte-pathogène › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Composés chimiques organiques › Composés onium › Composés d'ammonium quaternaire › Choline › Phosphoryl-choline › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à streptocoques › Infections à pneumocoques › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Métabolisme › Liaison aux protéines › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Streptococcaceae › Streptococcus › Streptococcus pneumoniae › Structure-Function Relationships of C-Reactive...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Structure-Function Relationships of C-Reactive...